Skip to main content
AMA Journal of Ethics®
Illuminating the Art of Medicine

Main navigation

  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • Topics
  • For Authors
  • Call for Papers
  • Call for Artwork
  • Call for Editorial Fellows
  • Art Collaborations
  • Register for Sep 10 Grand Rounds
  • En Español

Featured Content

Case and Commentary
Feb 2021

Fomento de la equidad en salud a través de un enfoque que evite los juicios de valor y contextualice la atención

Saul J. Weiner, MD

Cases

Topics
Core Competencies
Specialties
Language
Reset
  • cscm2-2001
    Case and Commentary
    Jan 2020

    How Should Clinicians Integrate Mental Health Into Epidemic Responses?

    Shantanu Srivatsa and Kearsley A. Stewart, PhD
    Culturally appropriate responsiveness to mental illnesses is critical to mitigating local persons’ distrust of international clinicians.
    AMA J Ethics. 2020;22(1):E10-15. doi: 10.1001/amajethics.2020.10.
  • cscm1-1912
    Case and Commentary
    Dec 2019

    How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions?

    Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD
    Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions.
    AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
  • cscm2-1912
    Case and Commentary
    Dec 2019

    Using the 4-S Framework to Guide Conversations With Patients About CRISPR

    Lisa S. Lehmann, MD, PhD, MSc
    Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences.
    AMA J Ethics. 2019;21(12):E1029-1035. doi: 10.1001/amajethics.2019.1029.
  • cscm3-1912
    Case and Commentary
    Dec 2019

    How Should “CRISPRed” Babies Be Monitored Over Their Life Course to Promote Health Equity?

    Charis Thompson, PhD
    Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.
    AMA J Ethics. 2019;21(12):E1036-1041. doi: 10.1001/amajethics.2019.1036.
  • cscm2-1911
    Case and Commentary
    Nov 2019

    Should a Caregiver’s QoL Be Considered in Decisions About Whether a Patient Has an Experimental Double-Hand Transplant?

    Miguel I. Dorante, MD, MBE, Elaine Devine, MSW, LICSW, and Simon G. Talbot, MD
    Success depends on strong support, rehabilitation, adherence, and social integration.
    AMA J Ethics. 2019;21(11):E943-952. doi: 10.1001/amajethics.2019.943.
  • cscm3-1911
    Case and Commentary
    Nov 2019

    How Should Surgeons Balance Transplantation Innovation With Acceptance of a Trauma Survivor’s Appearance?

    Carly Parnitzke Smith, PhD
    Counseling a patient about reconstructive surgery for a traumatic and disfiguring injury requires special consideration.
    AMA J Ethics. 2019;21(11):E953-959. doi: 10.1001/amajethics.2019.953.
  • cscm1-1911
    Case and Commentary
    Nov 2019

    In Experimental Hand Transplantation, Whose Views About Outcomes Should Matter Most?

    Andrea DiMartini, MD and Mary Amanda Dew, PhD
    Clinician-researchers deeply invested in data gathering are still obliged to respect a patient-subject’s right to stop being in research.
    AMA J Ethics. 2019;21(11):E936-942. doi: 10.1001/amajethics.2019.936.
  • cscm1-1910
    Case and Commentary
    Oct 2019

    How Should Clinical Ethics Consultants Support Parents’ Decision Making?

    Katherine J. Feder, MS and Janice I. Firn, PhD, LMSW
    Rather than relying on decision aids, values-based approaches to decision making illuminate a plurality of possible right actions.
    AMA J Ethics. 2019;21(10):E831-837. doi: 10.1001/amajethics.2019.831.
  • cscm4-1910
    Case and Commentary
    Oct 2019

    How Should Decision Science Inform Scarce Blood Product Allocation?

    Eric Kersjes, MD and Lauren B. Smith, MD
    Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation.
    AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
  • cscm2-1910
    Case and Commentary
    Oct 2019

    How Should a Physician Respond to a Patient’s Pain When New Opioid Prescribing Laws Limit Shared Decision Making?

    Alexander J. Hjelmaas, MD and Christian J. Vercler, MD, MA
    Regulations’ negative influence on patient-physician relationships can be mitigated by innovation in decision science.
    AMA J Ethics. 2019;21(10):E838-843. doi: 10.1001/amajethics.2019.838.

Pagination

  • First page « First
  • Previous page ‹ Prev
  • …
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Current page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • …
  • Next page Next ›
  • Last page Last »
AMA Journal of Ethics®
Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • Website Accessibility
  • FAQ
  • Contact
American Medical Association

Email Signup


We do not share email addresses and will only use yours to send new content alerts. (Add [email protected] to your contacts to help ensure receipt.)
Copyright 2025 American Medical Association. All Rights Reserved. ISSN 2376-6980